$2.61 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 93 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 63.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Buy | HORIZON PHARMA INVT LTDnote 2.500% 3/1 | $131,460,000 | +16.7% | 116,032,000 | +2.2% | 5.04% | +11.8% | |
| PTLA | Buy | PORTOLA PHARMACEUTICALS INC | $90,829,000 | +177.4% | 2,617,543 | +56.0% | 3.48% | +165.7% |
| MYL | Buy | MYLAN N V | $90,682,000 | +16.8% | 3,199,789 | +12.9% | 3.48% | +11.9% |
| AERI | Buy | AERIE PHARMACEUTICALS INC | $76,417,000 | +39.4% | 1,608,785 | +5.9% | 2.93% | +33.5% |
| IMMU | Buy | IMMUNOMEDICS INC | $72,898,000 | +178.7% | 3,794,783 | +107.0% | 2.80% | +167.0% |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $46,007,000 | +23.3% | 386,000 | +12.9% | 1.76% | +18.2% |
| DPLO | Buy | DIPLOMAT PHARMACY INC | $40,956,000 | +29.5% | 7,049,297 | +200.1% | 1.57% | +24.1% |
| AXGN | Buy | AXOGEN INC | $37,213,000 | +1640.6% | 1,767,006 | +1588.1% | 1.43% | +1559.3% |
| ALEC | New | ALECTOR INC | $36,634,000 | – | 1,956,923 | +100.0% | 1.40% | – |
| CNC | Buy | CENTENE CORP DEL | $35,418,000 | +7.4% | 667,000 | +133.2% | 1.36% | +2.9% |
| BKD | Buy | BROOKDALE SR LIVING INC | $33,962,000 | +19.5% | 5,161,355 | +21.7% | 1.30% | +14.5% |
| FATE | Buy | FATE THERAPEUTICS INC | $29,920,000 | +40.9% | 1,702,897 | +2.9% | 1.15% | +34.9% |
| SEM | Buy | SELECT MED HLDGS CORP | $28,793,000 | +35.6% | 2,043,527 | +47.8% | 1.10% | +29.9% |
| NTRA | Buy | NATERA INC | $27,277,000 | +55.9% | 1,322,834 | +5.6% | 1.05% | +49.4% |
| KNSA | Buy | KINIKSA PHARMACEUTICALS LTD | $23,663,000 | -25.4% | 1,310,259 | +16.1% | 0.91% | -28.5% |
| SIEN | Buy | SIENTRA INC | $23,429,000 | +17.2% | 2,730,632 | +73.6% | 0.90% | +12.2% |
| ADUS | Buy | ADDUS HOMECARE CORP | $16,083,000 | +1.7% | 252,915 | +8.6% | 0.62% | -2.5% |
| WVE | New | WAVE LIFE SCIENCES LTD | $15,336,000 | – | 394,737 | +100.0% | 0.59% | – |
| DBVT | New | DBV TECHNOLOGIES S Asponsored adr | $13,116,000 | – | 1,701,222 | +100.0% | 0.50% | – |
| SWAV | New | SHOCKWAVE MED INC | $10,448,000 | – | 312,146 | +100.0% | 0.40% | – |
| ARDX | Buy | ARDELYX INC | $9,196,000 | +73.4% | 3,284,298 | +10.8% | 0.35% | +66.5% |
| PTCT | New | PTC THERAPEUTICS INC | $8,921,000 | – | 237,000 | +100.0% | 0.34% | – |
| ATNX | Buy | ATHENEX INC | $7,618,000 | -1.7% | 621,859 | +1.8% | 0.29% | -5.8% |
| NEOS | Buy | NEOS THERAPEUTICS INC | $4,696,000 | +131.3% | 1,799,141 | +46.2% | 0.18% | +122.2% |
| New | CLOVIS ONCOLOGY INCnote 2.500% 9/1 | $4,647,000 | – | 5,000,000 | +100.0% | 0.18% | – | |
| AGLE | New | AEGLEA BIOTHERAPEUTICS INC | $4,025,000 | – | 500,046 | +100.0% | 0.15% | – |
| ITMR | New | ITAMAR MED LTDsponsored ads | $3,647,000 | – | 314,136 | +100.0% | 0.14% | – |
| HARP | New | HARPOON THERAPEUTICS INC | $2,699,000 | – | 285,000 | +100.0% | 0.10% | – |
| MNLO | New | MENLO THERAPEUTICS INC | $1,558,000 | – | 198,451 | +100.0% | 0.06% | – |
| MLNTQ | New | MELINTA THERAPEUTICS INC | $1,267,000 | – | 356,952 | +100.0% | 0.05% | – |
| EYPT | New | EYEPOINT PHARMACEUTICALS INC | $406,000 | – | 226,802 | +100.0% | 0.02% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
| CENTENE CORP DEL | 33 | Q2 2024 | 3.3% |
| BIOCRYST PHARMACEUTICALS INC | 32 | Q2 2024 | 2.2% |
| MOLINA HEALTHCARE INC | 27 | Q2 2024 | 1.7% |
| BROOKDALE SR LIVING INC | 26 | Q2 2024 | 2.2% |
| EHEALTH INC | 25 | Q3 2020 | 2.0% |
| INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
| DECIPHERA PHARMACEUTICALS IN | 24 | Q1 2024 | 2.0% |
| MYLAN NV | 23 | Q3 2020 | 6.2% |
| PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
| CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
| CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-09-17 |
| 3 | 2024-09-12 |
| N-PX | 2024-08-29 |
| 13F-HR | 2024-08-14 |
| 4 | 2024-07-17 |
| 4 | 2024-07-15 |
| 4 | 2024-07-11 |
| 4 | 2024-06-14 |
| 4 | 2024-06-03 |
| 13F-HR | 2024-05-15 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.